SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032093
Filing Date
2021-06-08
Accepted
2021-06-08 14:43:43
Documents
13
Period of Report
2021-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K urgn-8k_20210607.htm   iXBRL 8-K 132212
2 EX-10.1 urgn-ex101_6.htm EX-10.1 210142
  Complete submission text file 0001564590-21-032093.txt   513752

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA urgn-20210607.xsd EX-101.SCH 5768
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20210607_lab.xml EX-101.LAB 19461
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20210607_pre.xml EX-101.PRE 11624
6 EXTRACTED XBRL INSTANCE DOCUMENT urgn-8k_20210607_htm.xml XML 3565
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 211001948
SIC: 2834 Pharmaceutical Preparations